ClinicalTrials.gg
RecruitingNCT07810478Updated Sep 21, 2026

Criteria-Based Rehabilitation After Tibial Fracture Fixation: A Randomized Controlled Trial

An interventional study of Criteria-Based Progressive Loading and Functional Rehabilitation Program in Tibial Fracture, sponsored by Al-Azhar University. Recruiting at 1 site in Palestinian Territories. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This randomized controlled trial will evaluate the effectiveness of a criteria-based progressive loading and functional rehabilitation program compared with usual physiotherapy in adults following surgical fixation of traumatic tibial fractures in Gaza. Participants will be randomly allocated to either a structured 6-8-week rehabilitation program, in which progression is guided by predefined clinical and functional criteria while respecting orthopedic weight-bearing restrictions, or to usual physiotherapy. The primary outcome will be lower-limb function measured using the Lower Extremity Functional Scale (LEFS). Secondary outcomes will include functional mobility, walking endurance, pain, knee and ankle range of motion, functional ambulation, walking-aid dependence, and adverse events. Outcomes will be assessed at baseline, post-intervention, and follow-up. The study aims to determine whether a standardized criteria-based rehabilitation approach can improve functional recovery following traumatic tibial fracture fixation.

Read the detailed description

### Detailed Intervention Prescription

Participants allocated to the intervention group will receive a structured criteria-based progressive loading and functional rehabilitation program for approximately 6-8 weeks, consisting of 2-3 supervised physiotherapy sessions per week in addition to an individualized home exercise program. Each supervised session will last approximately 45-60 minutes and will include an individualized combination of joint mobility, muscle strengthening, balance, gait, and functional training according to the participant's clinical status and stage of recovery.

The fundamental principle of the intervention is that progression will be determined by predefined clinical and functional criteria rather than postoperative time alone. All weight-bearing and loading activities will strictly follow the restrictions prescribed by the treating orthopedic or surgical team. The physiotherapist will not independently advance a participant beyond the medically permitted weight-bearing level.

**Phase 1: Protection and Early Mobility**

During the initial phase, rehabilitation will focus on protecting the surgical site, controlling symptoms, maintaining joint mobility, minimizing muscle weakness, and achieving safe basic mobility. Treatment will include patient education, appropriate positioning, pain and edema management, active or active-assisted knee and ankle range-of-motion exercises as clinically permitted, quadriceps activation, hamstring and gluteal exercises, ankle exercises, and straight-leg raising when appropriate. Muscle activation and mobility exercises will generally be performed for 2-3 sets of 10-15 repetitions according to the participant's tolerance.

Functional rehabilitation during this phase will include bed mobility, transfer training, sit-to-stand practice when appropriate, and instruction in the safe use of crutches or a walker according to the prescribed weight-bearing status. Participants will also receive an individualized home exercise program focusing primarily on mobility and muscle activation.

Progression from this phase will not occur simply because a predetermined number of postoperative weeks has elapsed. Progression will be considered when the participant demonstrates satisfactory wound and soft-tissue status, controlled pain and swelling, improving knee and ankle mobility, safe transfers, appropriate performance of the prescribed exercises, and adequate neuromuscular control.

**Phase 2: Initial Loading and Gait Rehabilitation**

This phase will begin once increased loading or weight-bearing has been medically permitted by the orthopedic or surgical team. Treatment will focus on gradually introducing the permitted load to the affected limb and restoring safe functional mobility.

Interventions will include controlled weight-shifting activities, weight-bearing practice within the prescribed limits, gait retraining using the appropriate walking aid, progressive lower-limb strengthening, sit-to-stand training, supported balance exercises, continued knee and ankle mobility exercises, and progressive walking practice. Strengthening exercises will generally be performed for 2-3 sets of approximately 8-15 repetitions, with resistance adjusted according to the participant's clinical status and ability to perform the movement with appropriate control.

Gait training will emphasize safe loading of the affected limb within the prescribed restriction, appropriate step pattern, correct use of the walking aid, balance, and progressive improvement in walking quality. Walking duration and distance will be increased gradually according to tolerance.

Progression will be considered when the participant can tolerate the currently prescribed loading level without clinically significant worsening of pain, swelling, or other symptoms; demonstrate controlled weight transfer; perform functional activities with satisfactory movement control; and walk safely using the prescribed assistive device. Advancement to a higher weight-bearing level will occur only when permitted by the treating orthopedic team.

**Phase 3: Progressive Functional Loading**

As greater weight-bearing is medically permitted, rehabilitation will progressively emphasize functional loading, lower-limb strength, balance, gait quality, and independence. Treatment will include progressive closed-chain exercises, functional strengthening, repeated sit-to-stand practice, step-up and step-down activities, balance and proprioceptive exercises, progressive walking, and gait-quality training.

Exercises will generally be prescribed for approximately 2-4 sets of 8-15 repetitions depending on the exercise, participant tolerance, and functional goal. The difficulty of exercises will be progressively increased by modifying resistance, repetitions, movement complexity, balance demands, walking distance, or the amount of upper-limb support rather than progressing according to time alone.

Reliance on crutches, a walker, or other upper-limb support will be reduced gradually when clinically appropriate and when consistent with the prescribed weight-bearing status. The participant must demonstrate adequate balance and safe gait before progressing to a less supportive walking aid.

Progression to advanced functional rehabilitation will require satisfactory tolerance of the current loading level, controlled symptoms, adequate movement quality, improving functional mobility and balance, safe ambulation, and medical permission for further loading.

**Phase 4: Advanced Functional Rehabilitation**

Once full weight-bearing is medically permitted, rehabilitation will focus on restoring independent mobility and preparing the participant for community, daily living, and occupational activities. Treatment will include independent gait training, stair negotiation, uneven-surface walking, functional squatting, advanced balance and proprioceptive exercises, progressive lower-limb strengthening, walking endurance training, community mobility activities, and activities of daily living.

Where relevant, rehabilitation will also include work-, household-, or activity-specific tasks based on the participant's individual functional requirements. Walking duration and distance will be progressively increased, and the participant will be encouraged to achieve safe mobility with the least restrictive walking aid or without an assistive device when appropriate.

Throughout all phases, the physiotherapist will assess pain, swelling, range of motion, functional performance, gait safety, exercise tolerance, and any adverse clinical response. Exercise intensity or loading will be reduced or temporarily withheld if the participant develops clinically significant worsening of pain or swelling, wound problems, loss of functional performance, or other signs requiring medical reassessment. Suspected fixation-related complications, wound complications, or other significant adverse events will be referred to the treating medical or surgical team.

The home exercise program will be individualized according to the participant's current rehabilitation phase. Mobility and muscle-activation exercises may be performed daily, while strengthening, balance, gait, and functional activities will be prescribed according to clinical tolerance and safety. Adherence to the home program and supervised physiotherapy sessions will be documented.

The main distinction between this intervention and usual physiotherapy is therefore not the individual exercises themselves. Participants receiving usual physiotherapy may also receive range-of-motion exercises, strengthening, gait training, balance exercises, walking-aid training, and functional exercises. In the intervention group, however, rehabilitation will follow a standardized criteria-based pathway in which advancement, regression, and functional progression are determined by predefined clinical and functional milestones while remaining within the weight-bearing restrictions established by the orthopedic team.

02

Conditions studied

  • Tibial Fracture

Browse trials for

Keywords

  • tibial fractures
  • Criteria-based rehabilitation
  • Progressive loading
  • Weight-bearing; Functional rehabilitation
  • Functional recovery
03

In context

Tibial Fractures

135 studies on the registry are indexed under Tibial Fractures; 37 are open to participants now.

This study's planned enrollment of 120 is above the median of 65 across 91 interventional studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Traumatic unilateral tibial fracture involving the proximal tibia/tibial plateau, tibial shaft, or distal tibia.
  • Treated with surgical fixation.
  • Recruitment 2-8 weeks after the index fixation surgery.
  • Medically and surgically stable and cleared by the treating team to participate in physiotherapy.
  • Documented postoperative weight-bearing status/instructions from the treating orthopedic team.
  • Able to participate in the study rehabilitation and complete the planned functional assessments when permitted by weight-bearing status.
  • Able to understand study instructions and provide written .
  • Open fractures are eligible provided the wound is clinically stable, there is no active uncontrolled infection preventing rehabilitation, and rehabilitation has been authorized by the treating surgical team.

Exclusion criteria

Exclusion criteria:

  • Pathological fracture.
  • Unstable fixation, fixation failure, or any orthopedic/medical to progressive rehabilitation.
  • Active or uncontrolled infection requiring restriction or interruption of rehabilitation.
  • Lower-limb amputation affecting functional assessment.
  • Spinal cord injury or severe traumatic brain injury affecting mobility or ability to participate.
  • Pre-existing neurological disorder substantially affecting gait or lower-limb function.
  • Major concomitant injury to either lower limb that substantially limits walking or participation in the rehabilitation protocol.
  • Severe cognitive impairment preventing understanding of instructions, valid outcome assessment, or .
  • Any medical condition considered by the treating physician to make participation in the rehabilitation program unsafe.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Criteria-Based Progressive Loading and Functional Rehabilitation

    Participants assigned to the experimental arm will receive a structured criteria-based progressive loading and functional rehabilitation program for approximately 6-8 weeks, with 2-3 supervised physiotherapy sessions per week in addition to an individualized home exercise program. The program will progress through four rehabilitation phases according to predefined clinical and functional criteria rather than postoperative time alone. Phase 1 will focus on protection and early mobility and may include pain and edema management, positioning, knee and ankle range-of-motion exercises, quadriceps activation, hamstring and gluteal exercises, ankle exercises, bed mobility, transfer training, and safe use of walking aids. Phase 2 will introduce medically permitted loading through controlled weight shifting, weight-bearing practice, gait retraining, progressive strengthening, sit-to-stand training, supported balance exercises, and progressive walking. Phase 3 will emphasize progressive functi

    Other: Criteria-Based Progressive Loading and Functional Rehabilitation Program

  • Active comparator
    Usual Physiotherapy

    Participants assigned to the control arm will receive the usual physiotherapy rehabilitation routinely provided at the participating rehabilitation centers following surgical fixation of traumatic tibial fractures. Usual physiotherapy may include pain and edema management, knee and ankle range-of-motion exercises, muscle strengthening, gait training, balance exercises, walking-aid training, functional exercises, progressive walking, and home exercise advice according to routine clinical practice and the individual needs of the participant. Weight-bearing and loading will follow the instructions provided by the treating orthopedic or surgical team. Unlike the experimental arm, progression of rehabilitation will not be guided by the standardized study-specific criteria-based progression algorithm. The number and duration of physiotherapy sessions and the principal interventions received will be documented throughout the study.

    Other: Criteria-Based Progressive Loading and Functional Rehabilitation Program

Interventions

  • OtherCriteria-Based Progressive Loading and Functional Rehabilitation Program

    Participants will receive a structured Criteria-Based Progressive Loading and Functional Rehabilitation Program for 12 weeks, consisting of 2-3 supervised physiotherapy sessions per week plus an individualized home exercise program. Rehabilitation will progress through four phases: protection and early mobility; initial loading and gait rehabilitation; progressive functional loading; and advanced functional rehabilitation. Treatment will include pain and edema management, knee and ankle range-of-motion exercises, progressive lower-limb strengthening, weight-shifting and permitted weight-bearing practice, gait training, balance and proprioceptive exercises, sit-to-stand and step training, progressive walking, endurance training, and functional mobility activities. Progression will be based on predefined clinical and functional criteria rather than time alone and will remain within orthopedic weight-bearing restrictions. Participants will be followed for an additional 3 months after comp

06

What researchers measure

Primary outcomes

  1. Lower Extremity Functional Scale

    The LEFS will be used to assess lower-limb functional status and the participant's difficulty performing everyday activities. The scale consists of 20 items, each scored from 0 to 4, producing a total score ranging from 0 to 80. Higher scores indicate better lower-extremity function. The primary endpoint will be the between-group difference in change in LEFS from baseline to completion of the intervention.

    Time frame: pre, 12 weeks post and 3 months follow up

  2. Timed Up and Go Test (TUG)

    Functional mobility will be assessed using the TUG. Participants will stand from a chair, walk 3 meters, turn, walk back to the chair, and sit down. The total time required to complete the task will be recorded in seconds, with a shorter time indicating better functional mobility. The test will only be performed when medically appropriate according to the participant's weight-bearing status

    Time frame: pre, 12 weeks post and 3 months follow up

  3. Numeric Pain Rating Scale (NPRS)

    Pain intensity will be measured using an 11-point numeric rating scale from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Lower scores indicate less pain. Pain at rest and/or during functional activity will be documented according to the study assessment protocol

    Time frame: pre, 12 weeks post and 3 months follow up

  4. Functional Ambulation Category

    The FAC will be used to classify the participant's level of functional walking independence and the amount of physical assistance required during ambulation. It is an ordinal scale ranging from 0 to 5, where 0 indicates inability to walk or the need for assistance from two or more people and 5 indicates independent ambulation. Higher scores indicate greater walking independence

    Time frame: pre, 12 weeks post and 3 months follow up

Secondary outcomes

  1. ROM

    ROM will be measured

    Time frame: pre, 12 weeks post and 3 months follow up

  2. Walking-Aid Dependence

    The type of assistive device required for walking will be recorded at each assessment. Categories will include walker, two crutches, one crutch, cane, or no walking aid. Changes toward a less supportive device or independent walking will be used as a clinically meaningful indicator of functional recovery

    Time frame: pre, 12 weeks post and 3 months follow up

07

Study locations

1 of 1 sites recruiting
  • Mohammed Matar
    Gaza, Gaza Strip, Palestinian Territories
    Recruiting
08

References and documents

Publications

  • Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther. 1999 Apr;79(4):371-83. PubMed 10201543 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07810478
Responsible party
Mosab ALdabbas (Assistant Professor at Alazhar university, Gaza, Palestine, Al-Azhar University) — Principal investigator
First posted
Sep 9, 2026
Start date
Sep 18, 2026
Primary completion
Jun 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Mosab M Aldabbas, PhD
Contact
mosab.m.aldabbas@gmail.com
00972597451222

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion